ABSTRACT
Mycoplasma bovis is an important component of the bovine respiratory disease complex and recent reports identified that other species are also affected by M bovis. Control of the disease caused by M bovis has been unsuccessful owing to many factors, including the capacity of M bovis to evade and modulate the immune system of the host; the lack of known virulence factors; the absence of a cell wall, which renders antibiotics targeting cell-wall synthesis unusable; and the failure of vaccines to control disease on the field. The current knowledge on virulence and pathogenesis is presented in this review.
Subject(s)
Bovine Respiratory Disease Complex/microbiology , Mycoplasma Infections/veterinary , Mycoplasma bovis/pathogenicity , Animals , Bovine Respiratory Disease Complex/immunology , Cattle , Mycoplasma Infections/immunology , Mycoplasma Infections/microbiology , VirulenceABSTRACT
Mycoplasma bovis is a risky pathogen mainly responsible for pneumonia and mastitis in cattle. Up to date, its pathogenesis is not clear. Since secreted proteins have a tricky role in M. bovis pathogenesis, this study was designed to systematically reveal M. bovis secretome and potential role in virulence of the pathogen. By using bioinformatics tools, a total of 246 secreted proteins were predicted based on M. bovis genome. Among them, 14 were classical, 154 non-classical and 78 both pathways. Then by using 2-dimensional gel electrophoresis (2-DE) and Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF- MS), 169 proteins were revealed. Of them, 60 were predicted to be secreted including 3 classical, 43 non-classical, and 14 both classical and non-classical. Further 8 proteins (MbovP0038, MbovP0338, MbovP0341, MbovP0520, MbovP0581, MbovP0674, MbovP0693, MbovP0845) were predicted to be virulence-related factors with VFDB. In addition, MbovP0581 (ABC transporter protein) was validated experimentally as secreted in nature and highly immunogenic reacting with sera of cattle experimentally infected with M. bovis. In conclusion, this study might be a crucial step towards a better understanding of pathogenesis and leading to the development of novel diagnostic marker and potent vaccine against M. bovis.
Subject(s)
Bacterial Proteins/metabolism , Mycoplasma bovis/metabolism , Antibodies, Bacterial/immunology , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Conserved Sequence/genetics , Electrophoresis, Gel, Two-Dimensional , Genome, Bacterial/genetics , Genomics , Mass Spectrometry , Mycoplasma bovis/genetics , Mycoplasma bovis/pathogenicity , Proteomics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , VirulenceABSTRACT
Mycoplasma bovis is a critical bovine pathogen, but its pathogenesis remains poorly understood. Here, the virulent HB0801 (P1) and attenuated HB0801-P150 (P150) strains of M. bovis were used to explore the potential pathogenesis and effect of induced immunity from calves' differential transcriptomes post infection. Nine one-month-old male calves were infected with P1, P150, or mock-infected with medium and euthanized at 60 days post-infection. Calves in P1 group exhibited other clinical signs and pathological changes compared to the other two groups. Transcriptome profiles of peripheral blood mononuclear cells revealed seven and 10 hub differentially expressed genes (DEGs) in P1 and P150 groups compared with mock-infected group, respectively. Then, P1-induced pathogenesis was predicted to be associated with enhanced Th17, and P150-induced immunity with Th1 response and expression of ubiquitination-associated enzymes. Association analysis showed that 14 and 11 DEGs were positively and negatively correlated with pathological changes, respectively. Furthermore, up-regulated expression in molecules critical to differentiation of pathogenic Th17 cells in lung and peripheral blood mononuclear cells in P1 group was validated at RNA and protein levels. The results confirmed virulent and attenuated strains might be associated with biased differentiation of pro-inflammatory pathogenic Th17 and Th1 subsets respectively.
Subject(s)
Mycoplasma Infections/immunology , Mycoplasma bovis/pathogenicity , Th1 Cells/immunology , Th17 Cells/immunology , Transcriptome , Animals , Cattle , Cells, Cultured , Male , Mycoplasma Infections/genetics , Mycoplasma Infections/microbiology , Mycoplasma Infections/veterinaryABSTRACT
Mycoplasma bovis is an economically important pathogen of the cattle industry worldwide, and there is an urgent need for a more effective vaccine to control the diseases caused by this organism. Although the M. bovis genome sequence is available, very few gene functions of M. bovis have been experimentally determined, and a better understanding of the genes involved in pathogenesis are required for vaccine development. In this study, we compared the metabolite profiles of wild type M. bovis to a number of strains that each contained a transposon insertion into a putative transporter gene. Transport systems are thought to play an important role in survival of mycoplasmas, as they rely on the host for many nutrients. We also performed 13C-stable isotope labelling on strains with transposon insertions into putative glycerol transporters. Integration of metabolomic and bioinformatic analyses revealed unexpected results (when compared to genome annotation) for two mutants, with a putative amino acid transporter (MBOVPG45_0533) appearing more likely to transport nucleotide sugars, and a second mutant, a putative dicarboxylate/amino acid:cation (Na+ or H+) symporter (DAACS), more likely to function as a biopterin/folate transporter. This study also highlighted the apparent redundancy in some transport and metabolic pathways, such as the glycerol transport systems, even in an organism with a reduced genome. Overall, this study highlights the value of metabolomics for revealing the likely function of a number of transporters of M. bovis.
Subject(s)
Bacterial Proteins/metabolism , Carrier Proteins/metabolism , Computational Biology , Metabolomics , Mycoplasma Infections/veterinary , Mycoplasma bovis/genetics , Animals , Bacterial Proteins/genetics , Biopterins/metabolism , Carrier Proteins/genetics , Cattle , Cattle Diseases/microbiology , Genome, Bacterial , Metabolic Networks and Pathways , Mutation , Mycoplasma bovis/pathogenicityABSTRACT
Bacterial pathogens have evolved to manipulate host cell death and survival pathways for their intracellular persistence. Understanding the ability of a bacterium to induce or inhibit cell death is essential for elucidating the disease pathogenesis and suggesting potential therapeutic options to manage the infection. In recent years, apoptosis inhibition by different bacteria has been suggested as a mechanism of survival by allowing the pathogen to replicate and disseminate in the host. Mycoplasma bovis has evolved mechanisms to invade and modulate apoptosis of bovine peripheral blood mononuclear cells (PBMC), red blood cells (RBCs), primary macrophages and monocytes. To date, these mechanisms are poorly understood. Using apoptosis assays such as Annexin V binding, caspases activity, reactive oxygen species production, DNA fragmentation and differential gene expression we set out to determine how M. bovis modulates macrophage survival. Using the BoMac cell line, we report a significant reduction in STS-induced apoptosis through caspase dependent manner. Besides activating the NF-kß pathway and inhibiting caspases 3, 6 and 9, M. bovis strain Mb1 also inhibits production of reactive oxygen species and DNA fragmentation of the host cell. We also report a significant up-regulation of the anti-apoptotic genes Bcl-2 and Bcl-XL upon infection. Our results indicate that M. bovis strain Mb1 inhibits the intrinsic pathway of apoptosis and up-regulate survival genes in BoMac cells.
Subject(s)
Apoptosis , DNA Fragmentation , Macrophages/microbiology , Macrophages/pathology , Mycoplasma bovis/immunology , Animals , Annexin A5/metabolism , Caspases/metabolism , Cattle , Cell Line , Gene Expression , Genes, bcl-2/genetics , Host-Pathogen Interactions , Mycoplasma bovis/pathogenicity , NF-kappa B/metabolism , Reactive Oxygen Species/metabolism , Up-Regulation , bcl-X Protein/geneticsABSTRACT
Mycoplasma bovis causes bovine mycoplasmosis. The major clinical manifestations are pneumonia and mastitis. Recently an increase in the severity of mastitis cases was reported in Switzerland. At the molecular level, there is limited understanding of the mechanisms of pathogenicity of M. bovis. Host-pathogen interactions were primarily studied using primary bovine blood cells. Therefore, little is known about the impact of M. bovis on other cell types present in infected tissues. Clear in vitro phenotypes linked to the virulence of M. bovis strains or tissue predilection of specific M. bovis strains have not yet been described. We adapted bovine in vitro systems to investigate infection of epithelial cells with M. bovis using a cell line (MDBK: Madin-Darby bovine kidney cells) and two primary cells (PECT: bovine embryonic turbinate cells and bMec: bovine mammary gland epithelial cells). Two strains isolated before and after the emergence of severe mastitis cases were selected. Strain JF4278 isolated from a cow with mastitis and pneumonia in 2008 and strain L22/93 isolated in 1993 were used to assess the virulence of M. bovis genotypes toward epithelial cells with particular emphasis on mammary gland cells. Our findings indicate that M. bovis is able to adhere to and invade different epithelial cell types. Higher titers of JF4278 than L22/93 were observed in co-cultures with cells. The differences in titers reached between the two strains was more prominent for bMec cells than for MDBK and PECT cells. Moreover, M. bovis strain L22/93 induced apoptosis in MDBK cells and cytotoxicity in PECT cells but not in bMec cells. Dose-dependent variations in proliferation of primary epithelial cells were observed after M. bovis infection. Nevertheless, an indisputable phenotype that could be related to the increased virulence toward mammary gland cells is not obvious.
Subject(s)
Epithelial Cells/microbiology , Host-Pathogen Interactions , Mastitis, Bovine/physiopathology , Models, Theoretical , Mycoplasma Infections/veterinary , Mycoplasma bovis/growth & development , Pneumonia, Mycoplasma/veterinary , Animals , Cattle , Cells, Cultured , Genotype , Mastitis, Bovine/microbiology , Mycoplasma Infections/physiopathology , Mycoplasma bovis/classification , Mycoplasma bovis/genetics , Mycoplasma bovis/pathogenicity , Pneumonia, Mycoplasma/physiopathology , VirulenceABSTRACT
Mycoplasma bovis, one of the major pathogens of bovine respiratory disease, binds to respiratory epithelial cells resulting in severe pneumonia and tissue damage. This study was designed to identify the adhesive function of a putative 27-kDa M. bovis lipoprotein, encoded by the gene MBOV_RS03440 and designated as P27. The gene was cloned and overexpressed to produce antibodies against the recombinant P27 (rP27). The western blot and flow cytometry assay confirmed P27 to be a surface-localized protein, while ELISA confirmed it to be an immunogenic protein. Confocal immunofluorescence microscopy demonstrated that rP27 bound to embryonic bovine lung (EBL) cell monolayers in a dose-dependent manner. Furthermore, anti-rP27 antiserum inhibited the attachment of M. bovis to EBL cells demonstrating the binding specificity of P27 to EBL cells. The attachment of rP27 to EBL cells was mediated by fibronectin (Fn), an extracellular matrix component. The interaction between rP27 and Fn was qualitatively and quantitatively monitored by ligand immunoblot assay, ELISA, and biolayer interferometry. Collectively, these results indicate that P27 is a novel Fn-binding, immunogenic adhesive protein of M. bovis, thereby contributing to the further understanding of the molecular pathogenesis of M. bovis.
Subject(s)
Adhesins, Bacterial/metabolism , Bacterial Adhesion/physiology , Fibronectins/metabolism , Lipoproteins/immunology , Lipoproteins/metabolism , Mycoplasma bovis/pathogenicity , Pneumonia/veterinary , Respiratory Mucosa/microbiology , Adhesins, Bacterial/genetics , Animals , Antibodies, Bacterial/immunology , Cattle , Cattle Diseases/microbiology , Cells, Cultured , Lipoproteins/genetics , Mycoplasma bovis/genetics , Pneumonia/microbiology , Protein BindingABSTRACT
Mycoplasma bovis, a frequent contributor to polymicrobial respiratory disease in cattle, has recently emerged as a major health problem in North American bison. Strong circumstantial evidence suggests it can be the sole pathogen causing disease manifestations in outbreaks of mortality in bison, but direct evidence is lacking. The goal of this study was to compare clinical signs and lesions in bison and cattle experimentally infected with field isolates of M. bovis recovered from bison. Bison (nâ¯=â¯7) and cattle (nâ¯=â¯6), seronegative for anti-M. bovis IgG, were exposed intranasally to M. bovis and necropsied 4-6 weeks later. Blood and nasal swabs were collected on day 0 (before exposure), day 11 and at necropsy. Samples of lung, lymph node, liver and spleen were also collected at necropsy. The only clinical sign observed was an elevation in the core body temperature of bison during the first few weeks post-exposure. Grossly visible lesions were apparent at necropsy in the lungs of five bison and the lymph node of one bison, while none were evident in cattle. Histologic evaluation revealed moderate to severe pulmonary lesions in four bison but none in cattle. M. bovis was recovered from tissues demonstrating gross lesions and from the lymph nodes of one additional bison and two cattle. All animals seroconverted by the time of necropsy. These data provide the first direct evidence that M. bovis can be a sole or primary cause of respiratory disease in healthy bison, although the isolates used were unable to cause disease in healthy cattle.
Subject(s)
Bison/microbiology , Cattle/microbiology , Genotype , Mycoplasma Infections/veterinary , Mycoplasma bovis/genetics , Mycoplasma bovis/pathogenicity , Animals , Cattle Diseases/microbiology , Disease Outbreaks , Liver/microbiology , Liver/pathology , Lung/microbiology , Lung/pathology , Lymph Nodes/microbiology , Lymph Nodes/pathology , Mycoplasma Infections/microbiology , Mycoplasma bovis/isolation & purification , VirulenceABSTRACT
Mycoplasma é um patógeno altamente contagioso, podendo causar mastite, pneumonia, artrite, entre outras enfermidades. Seu isolamento requer meios e condições específicas devido ao seu crescimento fastidioso. Devido à complexidade do seu diagnóstico, acredita-se que a real prevalência de casos de mastite por micoplasma seja subestimada. O objetivo do presente estudo foi identificar a prevalência de Mycoplasma bovis em diferentes rebanhos de bovinos leiteiros no estado de São Paulo. O estudo foi dividido em fase de triagem, na qual colheram-se amostras de 67 tanques de expansão e a coleta individual, na qual propriedades positivas para M. bovis foram visitadas e colhidas amostras de leite de todos os animais com mastite clínica e subclínica. O diagnóstico laboratorial foi feito por meio da PCR e cultivo microbiológico específico. A prevalência de M. bovis encontrada na fase de triagem foi de 1,4%. Na fase individual, todas as amostras de leite, procedentes de propriedade positiva para M. bovis no tanque de expansão, foram negativas, o que permite concluir pela baixa prevalência do agente nas condições do presente estudo.(AU)
Mycoplasma is a highly contagious pathogen, which can cause mastitis, pneumonia, arthritis, among other diseases. Its isolation requires specific means and conditions due to its fastidious growth. Due to the complexity of its diagnosis, it is believed that the real prevalence of mastitis cases by Mycoplasma is underestimated. The objective of the present study was to identify the prevalence of Mycoplasma bovis in different dairy herds in the state of São Paulo. The study was divided into a screening phase in which samples were collected from 67 expansion tanks and individual collection, in which positive properties for M. bovis were visited and collected milk samples from all animals with clinical and subclinical mastitis. The laboratory diagnosis was made through PCR and specific microbiological culture. The prevalence of M. bovis found in the screening phase was 1.4%. In the individual phase, all milk samples from M. bovis positive property in the expansion tank were negative, which allows to conclude the low prevalence of the agent under the conditions of the present study.(AU)
Subject(s)
Animals , Female , Cattle , Cattle/microbiology , Mycoplasma bovis/classification , Mycoplasma bovis/pathogenicity , Milk/microbiology , Mastitis, BovineABSTRACT
There is a worldwide problem of disease caused by Mycoplasma (M.) bovis in cattle; it has a significant detrimental economic and animal welfare impact on cattle rearing. Infection can manifest as a plethora of clinical signs including mastitis, pneumonia, arthritis, keratoconjunctivitis, otitis media and genital disorders that may result in infertility and abortion. Current diagnosis and control information are reviewed and analysed to identify gaps in knowledge of the causative organism in respect of the disease pathology, diagnosis and control methods. The main considerations are as follows: no vaccines are commercially available; antimicrobial resistance is increasing; diagnostic and antimicrobial sensitivity testing needs to be improved; and a pen-side test would facilitate more rapid diagnosis and implementation of treatment with antimicrobials. More data on host susceptibility, stress factors, immune response and infectious dose levels are required. The impact of asymptomatic carriers, M. bovis survival in the environment and the role of wildlife in transmitting the disease also needs investigation. To facilitate development of vaccines, further analysis of more M. bovis genomes, its pathogenic mechanisms, including variable surface proteins, is required, along with reproducible disease models.
Subject(s)
Cattle Diseases/diagnosis , Cattle Diseases/prevention & control , Communicable Disease Control/methods , Mycoplasma Infections/veterinary , Mycoplasma bovis/isolation & purification , Animals , Anti-Bacterial Agents/therapeutic use , Bacterial Vaccines/administration & dosage , Cattle , Cattle Diseases/microbiology , Female , Mycoplasma Infections/diagnosis , Mycoplasma Infections/microbiology , Mycoplasma Infections/prevention & control , Mycoplasma bovis/pathogenicityABSTRACT
Mycoplasma bovis (M. bovis) is an important bacterium, causing severe respiratory infection, and arthritis in dairy animals worldwide. This study is based on 50 suckling calves among which 15 showed respiratory distress, lameness and swollen joints and died later. M. bovis was isolated and identified from all dead (n = 15) and live (17.14%; 06 out of 35) calves on the basis of bacteriological examination. In morbid calves, the carpus and stifle joints were severely affected, while necropsy revealed multiple well-circumscribed calcified abscesses and caseous exudates in cranio-ventral and diaphragmatic lobes of lungs. Suppurative polyarthritis, fibrino-suppurative, teno-synovitis and otitis media were the common and striking lesion observed at postmortem examination. Histopathological examination revealed broncho-interstitial pneumonia and necrotic fibrino-purulent broncho-pneumonia in lungs. Similarly, synovial membranes and joints revealed presence of multiple foci of liquefactive necrosis surrounded by lymphocytes, plasma cells, macrophages and peripheral fibroplasia. In the bacteriological investigations, the characteristic fried egg colonies of M. bovis further confirmed this infection in all suspected cases. In conclusion, the current clinico-histo-pathological features are the depictive picture, and is the first report of M. bovis infection in calves in Pakistan.
Subject(s)
Cattle Diseases/microbiology , Cattle Diseases/pathology , Disease Outbreaks/veterinary , Mycoplasma Infections/epidemiology , Mycoplasma Infections/microbiology , Mycoplasma Infections/pathology , Mycoplasma bovis/pathogenicity , Abscess/pathology , Animals , Arthritis/microbiology , Arthritis/pathology , Arthritis, Infectious , Autopsy , Cattle , Cattle Diseases/mortality , Lameness, Animal , Lung/microbiology , Lung/pathology , Male , Mortality , Mycoplasma Infections/mortality , Mycoplasma bovis/isolation & purification , Otitis Media, Suppurative/microbiology , Otitis Media, Suppurative/pathology , Pneumonia, Bacterial , Pneumonia, Mycoplasma/microbiology , Pneumonia, Mycoplasma/pathology , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/pathology , Synovitis/microbiology , Synovitis/pathologyABSTRACT
In the last few years, several outbreaks of pneumonia, systemically disseminated infection, and high mortality associated with Mycoplasma bovis (M. bovis) in North American bison (Bison bison) have been reported in Alberta, Manitoba, Saskatchewan, Nebraska, New Mexico, Montana, North Dakota, and Kansas. M. bovis causes Chronic Pneumonia and Polyarthritis Syndrome (CPPS) in young, stressed calves in intensively-managed feedlots. M. bovis is not classified as a primary pathogen in cattle, but in bison it appears to be a primary causative agent with rapid progression of disease with fatal outcomes and an average 20% mature herd mortality. Thus, there is a possibility that M. bovis isolates from cattle and bison differ in their pathogenicity. Hence, we decided to compare selected cattle isolates to several bison isolates obtained from clinical cases. We show differences in modulation of PBMC proliferation, invasion of trachea and lung epithelial cells, along with modulation of apoptosis and survival in alveolar macrophages. We concluded that some bison isolates showed less inhibition of cattle and bison PBMC proliferation, were not able to suppress alveolar macrophage apoptosis as efficiently as cattle isolates, and were more or less invasive than the cattle isolate in various cells. These findings provide evidence about the differential properties of M. bovis isolated from the two species and has helped in the selection of bison isolates for genomic sequencing.
Subject(s)
Apoptosis , Cattle Diseases/microbiology , Leukocytes, Mononuclear/microbiology , Macrophages, Alveolar/microbiology , Mycoplasma Infections/microbiology , Mycoplasma bovis/physiology , Animals , Bison , Cattle , Cattle Diseases/physiopathology , Cell Proliferation , Epithelial Cells/microbiology , Microbial Viability , Mycoplasma bovis/isolation & purification , Mycoplasma bovis/pathogenicityABSTRACT
Bovine respiratory disease (BRD) is an economically important disease of cattle and continues to be an intensely studied topic. However, literature summarizing the time between pathogen exposure and clinical signs, shedding, and seroconversion is minimal. A structured literature review of the published literature was performed to determine cattle responses (time from pathogen exposure to clinical signs, shedding, and seroconversion) in challenge models using common BRD viral and bacterial pathogens. After review a descriptive analysis of published studies using common BRD pathogen challenge studies was performed. Inclusion criteria were single pathogen challenge studies with no treatment or vaccination evaluating outcomes of interest: clinical signs, shedding, and seroconversion. Pathogens of interest included: bovine viral diarrhea virus (BVDV), bovine herpesvirus type 1 (BHV-1), parainfluenza-3 virus, bovine respiratory syncytial virus, Mannheimia haemolytica, Mycoplasma bovis, Pastuerella multocida, and Histophilus somni. Thirty-five studies and 64 trials were included for analysis. The median days to the resolution of clinical signs after BVDV challenge was 15 and shedding was not detected on day 12 postchallenge. Resolution of BHV-1 shedding resolved on day 12 and clinical signs on day 12 postchallenge. Bovine respiratory syncytial virus ceased shedding on day 9 and median time to resolution of clinical signs was on day 12 postchallenge. M. haemolytica resolved clinical signs 8 days postchallenge. This literature review and descriptive analysis can serve as a resource to assist in designing challenge model studies and potentially aid in estimation of duration of clinical disease and shedding after natural pathogen exposure.
Subject(s)
Bovine Respiratory Disease Complex/microbiology , Animals , Bovine Respiratory Disease Complex/virology , Cattle/microbiology , Cattle/virology , Diarrhea Viruses, Bovine Viral/pathogenicity , Herpesvirus 1, Bovine/pathogenicity , Mannheimia haemolytica/pathogenicity , Mycoplasma bovis/pathogenicity , Parainfluenza Virus 3, Bovine/pathogenicity , Pasteurella multocida/pathogenicity , Respiratory Syncytial Virus, Bovine/pathogenicityABSTRACT
Bovine mycoplasmosis due to Mycoplasma bovis causes several important bovine diseases such as pneumonia, mastitis, arthritis, otitis, genital disorders or keratoconjunctivitis. Variable surface lipoproteins, adhesion, invasion of host cells, modulation of the host immune system, biofilm formation and the release of secondary metabolites like hydrogen peroxide, as well as synergistic infections with other bacterial or viral pathogens are among the more significantly studied characteristics of the bacterium. The aim of this review is to summarize the current knowledge regarding the virulence of M. bovis and additionally, factors contributing to the dissemination and persistence of this pathogen in the bovine host will be discussed.
Subject(s)
Cattle Diseases/microbiology , Mycoplasma Infections/veterinary , Mycoplasma bovis/pathogenicity , Animals , Cattle , Cattle Diseases/transmission , Mycoplasma Infections/microbiology , Mycoplasma Infections/transmission , Mycoplasma bovis/immunology , VirulenceABSTRACT
It is well established that exposure either to elevated levels of glucocorticoids, or to Mycoplasma bovis (M. bovis), has a negative effect on bovine neutrophil function. The objective of this research was to determine whether in vitro treatment of bovine neutrophils by M. bovis strains (n=4) and glucocorticoids would additively impair phagocyte function. Twenty, healthy, dairy cows were enrolled. Whole blood was collected from all cows for neutrophil isolation. Phagocytosis and the generation of superoxide anion (O2(-)) were tested in vitro by incubation of neutrophils with FITC labeled Escherichia coli (E. coli) and cytochrome c after treatment. Treatments included: NM1-4D (neutrophils treated with dexamethasone and exposed to one of the four M. bovis strains); NM1-4 (neutrophils exposed to one of the four M. bovis strains only); ND (neutrophils treated with dexamethasone only); and N (non-treated control neutrophils). The overall percentages of neutrophils phagocytizing E. coli were: 32%, 51%, 37%, and 53% ± 5.25% for treatments NM1-4D, NM1-4, ND, and N, respectively. The overall statistically transformed means of phagocytized E. coli per neutrophil were: 1.37, 1.72, 1.33, and 1.67 ± 0.057 for treatments NM1-4D, NM1-4, ND, and N, respectively. The overall statistically transformed means of neutrophil O2(-) production were: 8.60, 11.91, 9.01, and 12.21 ± 0.21 nmol/10(6) for treatments NM1-4D, NM1-4, ND, and N, respectively. Exposure of neutrophils to M. bovis plus dexamethasone had an additive effect on generation of reactive oxygen species (p=0.0057), but not on the percentage of neutrophils phagocytizing E. coli (p=0.0817) or number of E. coli phagocytized per neutrophil (p=0.2946). Only one of the four M. bovis strains had a negative effect on neutrophil phagocytic function. Dexamethasone treatment consistently decreased neutrophil function as indicated by decreased percentage of neutrophils phagocytizing E. coli, decreased number of E. coli phagocytized per neutrophil, and decreased neutrophil O2(-) production, compared to controls (p<0.0001). Results suggested a synergistic effect of in vitro incubation of glucocorticoids and M. bovis on reduction of bovine neutrophil function as measured by generation of reactive oxygen species. These findings may explain in part the interaction between stressful events and outbreak of Mycoplasma bovis associated bovine disease.
Subject(s)
Dexamethasone/pharmacology , Mycoplasma bovis/immunology , Mycoplasma bovis/pathogenicity , Neutrophils/drug effects , Neutrophils/immunology , Animals , Cattle , Cattle Diseases/immunology , Cattle Diseases/microbiology , Escherichia coli/immunology , Female , Host-Pathogen Interactions/drug effects , Host-Pathogen Interactions/immunology , In Vitro Techniques , Mycoplasma Infections/immunology , Mycoplasma Infections/veterinary , Neutrophils/microbiology , Phagocytosis/drug effects , Phagocytosis/immunology , Reactive Oxygen Species/metabolism , Respiratory Burst/drug effects , Respiratory Burst/immunologySubject(s)
Cattle Diseases/microbiology , Lactation Disorders/veterinary , Mycoplasma Infections/veterinary , Mycoplasma bovis/pathogenicity , Otitis/veterinary , Animals , Cattle , Female , Lactation Disorders/microbiology , Mycoplasma Infections/complications , Otitis/microbiology , United KingdomABSTRACT
Mycoplasma membrane proteins influence cell shape, cell division, motility and adhesion to host cells, and are thought to be integrally involved in the pathogenesis of mycoplasmoses. Many of the membrane proteins predicted from mycoplasma genome sequences remain hypothetical, as their presence in cellular protein preparations is yet to be established experimentally. Recent genome sequences of several strains of Mycoplasma bovis have provided further insight into the potential role of the membrane proteins of this pathogen in colonisation and infection. This review highlights recent advances in knowledge about the influence of M. bovis membrane proteins on the pathogenesis of infection with this species and identifies future research directions for enhancing our understanding of the role of these proteins.
Subject(s)
Bacterial Outer Membrane Proteins/metabolism , Mycoplasma bovis/metabolism , Bacterial Outer Membrane Proteins/genetics , Gene Expression Regulation, Bacterial/physiology , Genome, Bacterial , Mycoplasma bovis/classification , Mycoplasma bovis/genetics , Mycoplasma bovis/pathogenicity , VirulenceABSTRACT
Tracheal antimicrobial peptide (TAP) is a ß-defensin produced by mucosal epithelial cells of cattle. Although effective against several human pathogens, the activity of this bovine peptide against the bacterial pathogens that cause bovine respiratory disease have not been reported. This study compared the antibacterial effects of synthetic TAP against Mannheimia haemolytica, Histophilus somni, Pasteurella multocida, and Mycoplasma bovis. Bactericidal activity against M. bovis was not detected. In contrast, the Pasteurellaceae bacteria showed similar levels of susceptibility to that of Escherichia coli, with 0.125µg TAP inhibiting growth in a radial diffusion assay and minimum inhibitory concentrations of 1.56-6.25µg/ml in a bactericidal assay. Significant differences among isolates were not observed. Sequencing of exon 2 of the TAP gene from 23 cattle revealed a prevalent non-synonymous single nucleotide polymorphism (SNP) A137G, encoding either serine or asparagine at residue 20 of the mature peptide. The functional effect of this SNP was tested against M. haemolytica using synthetic peptides. The bactericidal effect of the asparagine-containing peptide was consistently higher than the serine-containing peptide. Bactericidal activities were similar for an acapsular mutant of M. haemolytica compared to the wild type. These findings indicate that the Pasteurellaceae bacteria that cause bovine respiratory disease are susceptible to killing by bovine TAP and appear not to have evolved resistance, whereas M. bovis appears to be resistant. A non-synonymous SNP was identified in the coding region of the TAP gene, and the corresponding peptides vary in their bactericidal activity against M. haemolytica.
Subject(s)
Antimicrobial Cationic Peptides/immunology , Antimicrobial Cationic Peptides/pharmacology , Cattle Diseases/immunology , Respiratory Tract Infections/veterinary , Amino Acid Sequence , Amino Acid Substitution , Animals , Antimicrobial Cationic Peptides/genetics , Cattle/genetics , Cattle/immunology , Cattle Diseases/microbiology , Cattle Diseases/prevention & control , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Mannheimia haemolytica/drug effects , Mannheimia haemolytica/genetics , Mannheimia haemolytica/pathogenicity , Molecular Sequence Data , Mycoplasma bovis/drug effects , Mycoplasma bovis/pathogenicity , Pasteurella multocida/drug effects , Pasteurella multocida/pathogenicity , Pasteurellaceae/drug effects , Pasteurellaceae/pathogenicity , Polymorphism, Single Nucleotide , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/pharmacology , Respiratory Tract Infections/immunology , Respiratory Tract Infections/prevention & control , beta-Defensins/genetics , beta-Defensins/immunology , beta-Defensins/pharmacologyABSTRACT
Mycoplasma bovis pneumonia in cattle has been epidemic in China since 2008. To investigate M. bovis pathogenesis, we completed genome sequencing of strain HB0801 isolated from a lesioned bovine lung from Hubei, China. The genomic plasticity was determined by comparing HB0801 with M. bovis strain ATCC® 25523™/PG45 from cow mastitis milk, Chinese strain Hubei-1 from lesioned lung tissue, and 16 other Mycoplasmas species. Compared to PG45, the genome size of HB0801 was reduced by 11.7 kb. Furthermore, a large chromosome inversion (580 kb) was confirmed in all Chinese isolates including HB0801, HB1007, a strain from cow mastitis milk, and Hubei-1. In addition, the variable surface lipoproteins (vsp) gene cluster existed in HB0801, but contained less than half of the genes, and had poor identity to that in PG45, but they had conserved structures. Further inter-strain comparisons revealed other mechanisms of gene acquisition and loss in HB0801 that primarily involved insertion sequence (IS) elements, integrative conjugative element, restriction and modification systems, and some lipoproteins and transmembrane proteins. Subsequently, PG45 and HB0801 virulence in cattle was compared. Results indicated that both strains were pathogenic to cattle. The scores of gross pathological assessment for the control group, and the PG45- and HB0801-infected groups were 3, 13 and 9, respectively. Meanwhile the scores of lung lesion for these three groups were 36, 70, and 69, respectively. In addition, immunohistochemistry detection demonstrated that both strains were similarly distributed in lungs and lymph nodes. Although PG45 showed slightly higher virulence in calves than HB0801, there was no statistical difference between the strains (P>0.05). Compared to Hubei-1, a total of 122 SNP loci were disclosed in HB0801. In conclusion, although genomic plasticity was thought to be an evolutionary advantage, it did not apparently affect virulence of M. bovis strains in cattle.
Subject(s)
Genome, Bacterial/genetics , Mycoplasma bovis/genetics , Animals , Antigens, Bacterial/genetics , Bacterial Outer Membrane Proteins/genetics , Base Sequence , Cattle , China , Chromosome Inversion/genetics , Gene Transfer, Horizontal/genetics , Genome Components/genetics , Genomics , Multigene Family/genetics , Mycoplasma bovis/isolation & purification , Mycoplasma bovis/pathogenicity , Species SpecificityABSTRACT
Infection by Mycoplasma bovis (M. bovis) can induce diseases, such as pneumonia and otitis media in young calves and mastitis and arthritis in older animals. Here, we report the finished and annotated genome sequence of M. bovis strain Hubei-1, a strain isolated in 2008 that caused calf pneumonia on a Chinese farm. The genome of M. bovis strain Hubei-1 contains a single circular chromosome of 953,114 bp with a 29.37% GC content. We identified 803 open reading frames (ORFs) that occupy 89.5% of the genome. While 34 ORFs were Hubei-1 specific, 662 ORFs had orthologs in the M. bovis type strain PG45 genome. Genome analysis validated lateral gene transfer between M. bovis and the Mycoplasma mycoides subspecies mycoides, while phylogenetic analysis found that the closest M. bovis neighbor is Mycoplasma agalactiae. Glycerol may be the main carbon and energy source of M. bovis, and most of the biosynthesis pathways were incomplete. We report that 47 lipoproteins, 12 extracellular proteins and 18 transmembrane proteins are phase-variable and may help M. bovis escape the immune response. Besides lipoproteins and phase-variable proteins, genomic analysis found two possible pathogenicity islands, which consist of four genes and 11 genes each, and several other virulence factors including hemolysin, lipoate protein ligase, dihydrolipoamide dehydrogenase, extracellular cysteine protease and 5'-nucleotidase.